Having trouble accessing articles? Reset your cache.

Optimer begins fidaxomicin rolling NDA

Optimer Pharmaceuticals Inc. (NASDAQ:OPTR) began submission

Read the full 68 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE